CAS 50924-49-7
:Mizoribine
Description:
Mizoribine, with the CAS number 50924-49-7, is an immunosuppressive agent primarily used in the treatment of autoimmune diseases and organ transplantation. It is a purine analog that inhibits the synthesis of nucleotides, thereby affecting lymphocyte proliferation and function. Mizoribine is characterized by its ability to selectively suppress T and B cell activity, making it valuable in preventing graft rejection and managing conditions like rheumatoid arthritis. The compound is typically administered orally and is known for its relatively favorable side effect profile compared to other immunosuppressants. Its mechanism of action involves the inhibition of inosine monophosphate dehydrogenase, which is crucial for the de novo synthesis of purines. Mizoribine is also noted for its pharmacokinetic properties, including its metabolism and excretion, which can vary among individuals. Overall, Mizoribine represents an important therapeutic option in the field of immunology and transplant medicine, contributing to improved patient outcomes in various clinical settings.
Formula:C9H13N3O6
InChI:InChI=1S/C9H13N3O6/c10-7(16)4-8(17)12(2-11-4)9-6(15)5(14)3(1-13)18-9/h2-3,5-6,9,13-15,17H,1H2,(H2,10,16)/t3-,5-,6-,9-/m1/s1
InChI key:InChIKey=HZQDCMWJEBCWBR-UUOKFMHZSA-N
SMILES:O[C@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(O)=C(C(N)=O)N=C2
Synonyms:- 1H-Imidazole-4-carboxamide, 5-hydroxy-1-beta-D-ribofuranosyl-
- 1H-Imidazole-4-carboxamide, 5-hydroxy-1-β-<span class="text-smallcaps">D</span>-ribofuranosyl-
- 4-Carbamoyl-1-beta-D-ribofuranosyl-imidazolium-5-olate
- 5-Hydroxy-1-beta-D-ribofuranosyl-1H-imidazole-4-carboxamide
- 5-Hydroxy-1-beta-D-ribofuranosylimidazole-4-carboxamide
- 5-Hydroxy-1-β-<span class="text-smallcaps">D</span>-ribofuranosyl-1H-imidazole-4-carboxamide
- 5-hydroxy-1-pentofuranosyl-1H-imidazole-4-carboxamide
- Anhydro-4-carbamoyl-5-hydroxy-1-beta-D-ribofuranosyl-imidazolium hydroxide
- Bredinin
- Bredinine
- Brn 4151713
- He-69
- MZR
- Mizoribina
- Mizoribina [INN-Spanish]
- Mizoribinum
- NSC 289637
- Unii-4Jr41A10Vp
- β-Bredinin
- 1H-Imidazole-4-carboxamide, 5-hydroxy-1-β-D-ribofuranosyl-
- Mizoribine
- See more synonyms
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 17 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Mizoribine
CAS:Formula:C9H13N3O6Purity:>98.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:259.221-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)-5-Hydroxy-1H-Imidazole-4-Carboxamide
CAS:1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)-5-Hydroxy-1H-Imidazole-4-CarboxamideFormula:C9H13N3O6Purity:98%Molecular weight:259.225-Hydroxy-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide
CAS:Formula:C9H13N3O6Purity:98%Color and Shape:SolidMolecular weight:259.2160Mizoribine
CAS:Mizoribine (NSC-289637) belongs to the family of 1-Ribosyl-imidazolecarboxamides. Mizoribine has been investigated for the treatment of Rheumatoid Arthritis.Formula:C9H13N3O6Purity:98.38% - 99.95%Color and Shape:White SolidMolecular weight:259.22Mizoribine (Standard)
CAS:Mizoribine (Standard) is a reference standard for research and analysis in studies involving Mizoribine. Mizoribine (NSC-289637) belongs to the family of 1-Ribosyl-imidazolecarboxamides. Mizoribine has been investigated for the treatment of Rheumatoid Arthritis.Formula:C9H13N3O6Molecular weight:259.22Mizoribine
CAS:1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-hydroxy-1H-imidazole-4-carboxamideFormula:C9H13N3O6Purity:98%Molecular weight:259.22Mizoribine
CAS:Inhibitor of heat shock protein Hsp60; immunosuppressant
Formula:C9H13N3O6Purity:Min. 95%Color and Shape:White PowderMolecular weight:259.22 g/molMizoribine
CAS:M05728 - Mizoribine
Formula:C9H13N3O6Purity:98%Color and Shape:SolidMolecular weight:259.218Mizoribine-13C2,15N
CAS:Controlled ProductFormula:C2C7H1315NN2O6Color and Shape:NeatMolecular weight:262.195











